Annual Revenue
$1.03 B
+$184.23 M+21.74%
31 March 2022
Summary:
Abiomed annual revenue is currently $1.03 billion, with the most recent change of +$184.23 million (+21.74%) on 31 March 2022. During the last 3 years, it has risen by +$184.23 million (+21.74%).ABMD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$265.92 M
-$11.23 M-4.05%
30 September 2022
Summary:
Abiomed quarterly revenue is currently $265.92 million, with the most recent change of -$11.23 million (-4.05%) on 30 September 2022.ABMD Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$1.07 B
+$17.78 M+1.68%
30 September 2022
Summary:
Abiomed TTM revenue is currently $1.07 billion, with the most recent change of +$17.78 million (+1.68%) on 30 September 2022.ABMD TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +21.7% | +1.8% | +7.1% |
5 y5 years | +34.1% | +20.0% | +27.7% |
ABMD Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | at high | -4.1% | at high |
Abiomed Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2022 | - | $265.92 M(-4.1%) | $1.07 B(+1.7%) |
June 2022 | - | $277.15 M(+2.7%) | $1.06 B(+2.4%) |
Mar 2022 | $1.03 B(+21.7%) | $269.85 M(+3.3%) | $1.03 B(+2.9%) |
Dec 2021 | - | $261.18 M(+5.3%) | $1.00 B(+3.0%) |
Sept 2021 | - | $248.14 M(-1.8%) | $973.63 M(+4.1%) |
June 2021 | - | $252.59 M(+4.7%) | $935.26 M(+10.4%) |
Mar 2021 | $847.52 M(+0.8%) | $241.25 M(+4.1%) | $847.52 M(+4.3%) |
Dec 2020 | - | $231.66 M(+10.4%) | $812.93 M(+1.3%) |
Sept 2020 | - | $209.76 M(+27.2%) | $802.86 M(+0.6%) |
June 2020 | - | $164.85 M(-20.2%) | $798.07 M(-5.1%) |
Mar 2020 | $840.88 M(+9.3%) | $206.66 M(-6.7%) | $840.88 M(-0.1%) |
Dec 2019 | - | $221.58 M(+8.1%) | $841.30 M(+2.6%) |
Sept 2019 | - | $204.97 M(-1.3%) | $820.28 M(+2.9%) |
June 2019 | - | $207.67 M(+0.3%) | $797.09 M(+3.6%) |
Mar 2019 | $769.43 M(+29.6%) | $207.08 M(+3.2%) | $769.43 M(+4.4%) |
Dec 2018 | - | $200.56 M(+10.3%) | $736.79 M(+6.7%) |
Sept 2018 | - | $181.78 M(+1.0%) | $690.25 M(+7.6%) |
June 2018 | - | $180.01 M(+3.2%) | $641.29 M(+8.0%) |
Mar 2018 | $593.75 M(+33.3%) | $174.44 M(+13.3%) | $593.75 M(+9.1%) |
Dec 2017 | - | $154.02 M(+16.0%) | $543.99 M(+7.8%) |
Sept 2017 | - | $132.82 M(+0.3%) | $504.64 M(+6.3%) |
June 2017 | - | $132.47 M(+6.2%) | $474.78 M(+6.6%) |
Mar 2017 | $445.30 M(+35.1%) | $124.68 M(+8.7%) | $445.30 M(+7.4%) |
Dec 2016 | - | $114.67 M(+11.4%) | $414.58 M(+7.5%) |
Sept 2016 | - | $102.95 M(-0.0%) | $385.70 M(+7.4%) |
June 2016 | - | $103.00 M(+9.6%) | $359.11 M(+9.0%) |
Mar 2016 | $329.54 M(+43.1%) | $93.96 M(+9.5%) | $329.54 M(+8.7%) |
Dec 2015 | - | $85.80 M(+12.4%) | $303.14 M(+8.5%) |
Sept 2015 | - | $76.36 M(+4.0%) | $279.35 M(+9.6%) |
June 2015 | - | $73.43 M(+8.7%) | $254.93 M(+10.7%) |
Mar 2015 | $230.31 M(+25.4%) | $67.56 M(+9.0%) | $230.31 M(+8.0%) |
Dec 2014 | - | $62.01 M(+19.4%) | $213.19 M(+8.0%) |
Sept 2014 | - | $51.94 M(+6.4%) | $197.38 M(+4.0%) |
June 2014 | - | $48.81 M(-3.2%) | $189.78 M(+3.3%) |
Mar 2014 | $183.64 M(+16.1%) | $50.43 M(+9.2%) | $183.64 M(+3.8%) |
Dec 2013 | - | $46.20 M(+4.2%) | $176.88 M(+4.7%) |
Sept 2013 | - | $44.34 M(+3.9%) | $168.94 M(+4.3%) |
June 2013 | - | $42.67 M(-2.3%) | $162.01 M(+2.5%) |
Mar 2013 | $158.12 M(+25.1%) | $43.67 M(+14.2%) | $158.12 M(+4.2%) |
Dec 2012 | - | $38.25 M(+2.2%) | $151.79 M(+4.2%) |
Sept 2012 | - | $37.42 M(-3.5%) | $145.74 M(+5.8%) |
June 2012 | - | $38.78 M(+3.9%) | $137.80 M(+9.0%) |
Mar 2012 | $126.38 M(+24.9%) | $37.34 M(+16.0%) | $126.38 M(+7.5%) |
Dec 2011 | - | $32.20 M(+9.2%) | $117.56 M(+4.4%) |
Sept 2011 | - | $29.48 M(+7.8%) | $112.61 M(+5.7%) |
June 2011 | - | $27.36 M(-4.1%) | $106.50 M(+5.3%) |
Mar 2011 | $101.15 M(+18.0%) | $28.53 M(+4.7%) | $101.15 M(+5.8%) |
Dec 2010 | - | $27.24 M(+16.5%) | $95.60 M(+4.9%) |
Sept 2010 | - | $23.38 M(+6.2%) | $91.16 M(+3.8%) |
June 2010 | - | $22.00 M(-4.3%) | $87.80 M(+2.4%) |
Mar 2010 | $85.71 M(+17.1%) | $22.98 M(+0.8%) | $85.71 M(+4.1%) |
Dec 2009 | - | $22.80 M(+13.9%) | $82.32 M(+7.2%) |
Sept 2009 | - | $20.02 M(+0.5%) | $76.79 M(+0.0%) |
June 2009 | - | $19.91 M(+1.7%) | $76.77 M(+4.9%) |
Mar 2009 | $73.21 M(+24.2%) | $19.58 M(+13.4%) | $73.21 M(+2.9%) |
Dec 2008 | - | $17.27 M(-13.6%) | $71.13 M(+1.8%) |
Sept 2008 | - | $20.00 M(+22.3%) | $69.88 M(+14.1%) |
June 2008 | - | $16.36 M(-6.6%) | $61.23 M(+3.9%) |
Mar 2008 | $58.94 M(+16.4%) | $17.51 M(+9.3%) | $58.94 M(+6.6%) |
Dec 2007 | - | $16.02 M(+41.0%) | $55.28 M(+6.0%) |
Sept 2007 | - | $11.36 M(-19.3%) | $52.17 M(+0.9%) |
June 2007 | - | $14.06 M(+1.5%) | $51.70 M(+2.1%) |
Mar 2007 | $50.65 M(+16.0%) | $13.85 M(+7.3%) | $50.65 M(+0.1%) |
Dec 2006 | - | $12.90 M(+18.5%) | $50.59 M(+5.0%) |
Sept 2006 | - | $10.89 M(-16.3%) | $48.20 M(-0.1%) |
June 2006 | - | $13.01 M(-5.7%) | $48.26 M(+10.5%) |
Mar 2006 | $43.67 M(+14.3%) | $13.80 M(+31.2%) | $43.67 M(+7.4%) |
Dec 2005 | - | $10.52 M(-3.8%) | $40.65 M(+2.4%) |
Sept 2005 | - | $10.94 M(+29.8%) | $39.70 M(+1.3%) |
June 2005 | - | $8.42 M(-21.8%) | $39.20 M(+2.6%) |
Mar 2005 | $38.22 M | $10.77 M(+12.6%) | $38.22 M(+5.1%) |
Dec 2004 | - | $9.57 M(-8.3%) | $36.36 M(+9.1%) |
Sept 2004 | - | $10.44 M(+40.3%) | $33.32 M(+18.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2004 | - | $7.44 M(-16.5%) | $28.22 M(+9.0%) |
Mar 2004 | $25.74 M(+10.4%) | $8.91 M(+36.6%) | $25.88 M(+7.4%) |
Dec 2003 | - | $6.53 M(+22.2%) | $24.10 M(+4.0%) |
Sept 2003 | - | $5.34 M(+4.7%) | $23.16 M(-1.0%) |
June 2003 | - | $5.10 M(-28.5%) | $23.40 M(-0.9%) |
Mar 2003 | $23.31 M(-13.5%) | $7.13 M(+27.6%) | $23.61 M(-13.2%) |
Dec 2002 | - | $5.59 M(+0.3%) | $27.19 M(-1.2%) |
Sept 2002 | - | $5.58 M(+5.1%) | $27.51 M(+4.7%) |
June 2002 | - | $5.31 M(-50.5%) | $26.27 M(-2.5%) |
Mar 2002 | $26.96 M(+17.9%) | $10.72 M(+81.4%) | $26.96 M(+32.7%) |
Dec 2001 | - | $5.91 M(+36.0%) | $20.32 M(-0.2%) |
Sept 2001 | - | $4.34 M(-27.5%) | $20.36 M(-11.5%) |
June 2001 | - | $5.99 M(+47.1%) | $23.00 M(+0.6%) |
Mar 2001 | $22.87 M(+1.5%) | $4.07 M(-31.5%) | $22.87 M(-7.8%) |
Dec 2000 | - | $5.95 M(-14.8%) | $24.81 M(+0.2%) |
Sept 2000 | - | $6.99 M(+19.2%) | $24.76 M(+12.7%) |
June 2000 | - | $5.86 M(-2.6%) | $21.98 M(-2.2%) |
Mar 2000 | $22.52 M(+1.9%) | $6.02 M(+2.0%) | $22.47 M(-0.8%) |
Dec 1999 | - | $5.90 M(+40.5%) | $22.65 M(+3.5%) |
Sept 1999 | - | $4.20 M(-33.9%) | $21.88 M(-3.4%) |
June 1999 | - | $6.35 M(+2.4%) | $22.65 M(+2.5%) |
Mar 1999 | $22.10 M(-1.3%) | $6.20 M(+21.0%) | $22.10 M(+4.3%) |
Dec 1998 | - | $5.13 M(+3.2%) | $21.20 M(+2.5%) |
Sept 1998 | - | $4.97 M(-14.4%) | $20.67 M(-8.1%) |
June 1998 | - | $5.80 M(+9.5%) | $22.50 M(+0.5%) |
Mar 1998 | $22.40 M(+49.3%) | $5.30 M(+15.2%) | $22.40 M(+5.3%) |
Dec 1997 | - | $4.60 M(-32.4%) | $21.27 M(+6.4%) |
Sept 1997 | - | $6.80 M(+19.3%) | $19.99 M(+17.5%) |
June 1997 | - | $5.70 M(+36.8%) | $17.01 M(+13.3%) |
Mar 1997 | $15.00 M(+16.8%) | $4.17 M(+25.4%) | $15.01 M(+4.8%) |
Dec 1996 | - | $3.32 M(-13.2%) | $14.33 M(-1.3%) |
Sept 1996 | - | $3.83 M(+3.5%) | $14.52 M(+5.2%) |
June 1996 | - | $3.70 M(+6.3%) | $13.80 M(+7.4%) |
Mar 1996 | $12.84 M(+39.6%) | $3.48 M(-0.8%) | $12.84 M(+7.4%) |
Dec 1995 | - | $3.51 M(+13.0%) | $11.96 M(+6.3%) |
Sept 1995 | - | $3.11 M(+13.2%) | $11.25 M(+10.9%) |
June 1995 | - | $2.74 M(+5.5%) | $10.14 M(+9.1%) |
Mar 1995 | $9.20 M(+37.3%) | $2.60 M(-7.1%) | $9.30 M(+10.7%) |
Dec 1994 | - | $2.80 M(+40.0%) | $8.40 M(+13.5%) |
Sept 1994 | - | $2.00 M(+5.3%) | $7.40 M(+2.8%) |
June 1994 | - | $1.90 M(+11.8%) | $7.20 M(+7.5%) |
Mar 1994 | $6.70 M(+97.1%) | $1.70 M(-5.6%) | $6.70 M(+11.7%) |
Dec 1993 | - | $1.80 M(0.0%) | $6.00 M(+13.2%) |
Sept 1993 | - | $1.80 M(+28.6%) | $5.30 M(+26.2%) |
June 1993 | - | $1.40 M(+40.0%) | $4.20 M(+23.5%) |
Mar 1993 | $3.40 M(+25.9%) | $1.00 M(-9.1%) | $3.40 M(+9.7%) |
Dec 1992 | - | $1.10 M(+57.1%) | $3.10 M(+19.2%) |
Sept 1992 | - | $700.00 K(+16.7%) | $2.60 M(0.0%) |
June 1992 | - | $600.00 K(-14.3%) | $2.60 M(-3.7%) |
Mar 1992 | $2.70 M(+35.0%) | $700.00 K(+16.7%) | $2.70 M(+8.0%) |
Dec 1991 | - | $600.00 K(-14.3%) | $2.50 M(+4.2%) |
Sept 1991 | - | $700.00 K(0.0%) | $2.40 M(+9.1%) |
June 1991 | - | $700.00 K(+40.0%) | $2.20 M(+10.0%) |
Mar 1991 | $2.00 M(-33.3%) | $500.00 K(0.0%) | $2.00 M(-13.0%) |
Dec 1990 | - | $500.00 K(0.0%) | $2.30 M(-11.5%) |
Sept 1990 | - | $500.00 K(0.0%) | $2.60 M(-7.1%) |
June 1990 | - | $500.00 K(-37.5%) | $2.80 M(-6.7%) |
Mar 1990 | $3.00 M(+3.4%) | $800.00 K(0.0%) | $3.00 M(+3.4%) |
Dec 1989 | - | $800.00 K(+14.3%) | $2.90 M(0.0%) |
Sept 1989 | - | $700.00 K(0.0%) | $2.90 M(0.0%) |
June 1989 | - | $700.00 K(0.0%) | $2.90 M(0.0%) |
Mar 1989 | $2.90 M(-31.0%) | $700.00 K(-12.5%) | $2.90 M(-6.5%) |
Dec 1988 | - | $800.00 K(+14.3%) | $3.10 M(-11.4%) |
Sept 1988 | - | $700.00 K(0.0%) | $3.50 M(-10.3%) |
June 1988 | - | $700.00 K(-22.2%) | $3.90 M(-7.1%) |
Mar 1988 | $4.20 M(-10.6%) | $900.00 K(-25.0%) | $4.20 M(-6.7%) |
Dec 1987 | - | $1.20 M(+9.1%) | $4.50 M(0.0%) |
Sept 1987 | - | $1.10 M(+10.0%) | $4.50 M(-2.2%) |
June 1987 | - | $1.00 M(-16.7%) | $4.60 M(-2.1%) |
Mar 1987 | $4.70 M | $1.20 M(0.0%) | $4.70 M(+34.3%) |
Dec 1986 | - | $1.20 M(0.0%) | $3.50 M(+52.2%) |
Sept 1986 | - | $1.20 M(+9.1%) | $2.30 M(+109.1%) |
June 1986 | - | $1.10 M | $1.10 M |
FAQ
- What is Abiomed annual revenue?
- What is the all time high annual revenue for Abiomed?
- What is Abiomed quarterly revenue?
- What is the all time high quarterly revenue for Abiomed?
- What is Abiomed TTM revenue?
- What is the all time high TTM revenue for Abiomed?
What is Abiomed annual revenue?
The current annual revenue of ABMD is $1.03 B
What is the all time high annual revenue for Abiomed?
Abiomed all-time high annual revenue is $1.03 B
What is Abiomed quarterly revenue?
The current quarterly revenue of ABMD is $265.92 M
What is the all time high quarterly revenue for Abiomed?
Abiomed all-time high quarterly revenue is $277.15 M
What is Abiomed TTM revenue?
The current TTM revenue of ABMD is $1.07 B
What is the all time high TTM revenue for Abiomed?
Abiomed all-time high TTM revenue is $1.07 B